Real-world genomic profiling of acute myeloid leukemia and the impact of European LeukemiaNet risk stratification 2022 update.
Susana Elaine Alves da RosaLarissa Barbosa de LimaCaroline Nunes SilveiraLuiz Gustavo Ferreira CortesJoão Bosco de Oliveira FilhoRodrigo de Souza ReisMurilo Castro CervatoPedro Henrique Sebe RodriguesKarla de Oliveira PelegrinoRoberta Cardoso PetroniErica da Silva AraujoPaulo Vidal CampregherPublished in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2023)
In conclusion, we have described a real-world genomic profiling experience in AML and the impact of the 2022 ELN update on risk stratification.